Search

Gary C Visor

from Redwood City, CA
Age ~69
Get Report
Also known as:
Gary Dr Visor, Gary V Visor, Jill M Visor, Gary R
Phone and address:
970 Upland Rd, Redwood City, CA 94062
Related to:
Bernice B VisorJill Visor, 66
Connected to:
Linda F Visor, 77Francisco I Visoso, 53Marcos Visoso, 34Rosa M Visoso, 51Amy Visotsky, 49Dario Visotzky, 55Terri L Visovatti, 50Christopher G Visperas, 37Jenny L Visperas, 34Lhalaine Visperas, 46

Gary Visor Phones & Addresses

  • 970 Upland Rd, Redwood City, CA 94062
  • Menlo Park, CA
  • 2735 Saint James Rd, Belmont, CA 94002 (650) 578-8549 (650) 593-3329
  • 105 Canter Ct, Smithtown, NY 11787 (631) 979-6168
  • 20018 Jensen Ranch Rd, Castro Valley, CA 94552
  • Hayward, CA
  • Farmingdale, NY
  • Plainview, NY
  • San Diego, CA
  • Alameda, CA
  • Foster City, CA

Resumes

Resumes

Gary Visor Photo 1

Vice President, Technical Operations

View page
Location:
970 Upland Rd, Redwood City, CA 94062
Industry:
Biotechnology
Work:
Astellas Pharma Us
Vice President, Technical Operations
Gary Visor Photo 2

Vice President, Analytical Operations At Gilead Sciences

View page
Position:
Vice President, Analytical Operations at Gilead Sciences
Location:
San Francisco Bay Area
Industry:
Biotechnology
Work:
Gilead Sciences since Jun 2013
Vice President, Analytical Operations
Plexxikon, Inc. - Berkeley, CA Apr 2007 - Apr 2013
V.P. Molecular Pharmaceutics
OSI Pharmaceuticals Jan 2005 - Apr 2007
Vice President, Technical Operations

Business Records

Name / Title
Company / Classification
Phones & Addresses
Gary C. Visor
Vpl Pharma Group, LLC
20018 Jensen Rnch Rd, Hayward, CA 94552

Publications

Us Patents

Mtor Inhibitor Salt Forms

View page
US Patent:
8557814, Oct 15, 2013
Filed:
Mar 18, 2009
Appl. No.:
12/922928
Inventors:
Arlindo L. Castelhano - New City NY, US
Kristen Michelle Mulvihill - Dix Hills NY, US
Gary C. Visor - Castro Valley CA, US
Assignee:
OSI Pharmaceuticals, LLC - Farmingdale NY
International Classification:
A61K 31/53
C07D 487/04
US Classification:
514243, 544184
Abstract:
Salt forms of mTOR inhibitors of the Formula (I):.

Stabilized Fromulations Comprising Hydrolytically Unstable Compositions

View page
US Patent:
20020086057, Jul 4, 2002
Filed:
Nov 9, 2001
Appl. No.:
10/037875
Inventors:
Debra Odink - Mountain View CA, US
I-Lan Sue - San Jose CA, US
Gary Visor - Belmont CA, US
International Classification:
A61K009/48
A61K009/30
A61K031/4164
US Classification:
424/475000, 514/396000
Abstract:
This invention relates to new stable oral pharmaceutical formulations prepared by covering an nucleus formed by a core with a first hydrophobic polymer layer, a second layer coating the first layer, wherein said second layer comprises one or more labile pharmaceutical compounds in one or more acceptable hydrophobic excipients, and an optional third enteric polymer layer.

Stabilized Formulations Comprising Hydrolytically Unstable Compositions

View page
US Patent:
20040170689, Sep 2, 2004
Filed:
Mar 11, 2004
Appl. No.:
10/798856
Inventors:
Debra Odink - Mountain View CA, US
I-Lan Sue - San Jose CA, US
Gary Visor - Belmont CA, US
International Classification:
A61K009/46
A61K009/24
US Classification:
424/471000, 514/401000
Abstract:
This invention relates to new stable oral pharmaceutical formulations prepared by covering an nucleus formed by a core with a first hydrophobic polymer layer, a second layer coating the first layer, wherein said second layer comprises one or more labile pharmaceutical compounds in one or more acceptable hydrophobic excipients, and an optional third enteric polymer layer.

Method Of Treating Hepatitis Virus Infection With A Multiphasic Interferon Delivery Profile

View page
US Patent:
20050063949, Mar 24, 2005
Filed:
Sep 26, 2002
Appl. No.:
10/490458
Inventors:
Gary Visor - Belmont CA, US
International Classification:
A61K038/21
A61K009/22
US Classification:
424085700, 604890100
Abstract:
The present invention provides methods of treating hepatitis virus infection. The methods generally involve administering a composition comprising an antiviral agent in a dosing regimen that achieves a multiphasic serum concentration profile of the antiviral agent. The dosing regiment includes dosing events that are less frequent than with currently available hepatitis therapies. The multiphasic antiviral agent serum concentration profile that is achieved using the methods of the invention effects an initial rapid drop in viral titer, followed by a further decrease in viral titer over time, to achieve a sustained viral response

Compositions And Method For Treating Hepatitis Virus Infection

View page
US Patent:
20050095224, May 5, 2005
Filed:
Dec 5, 2002
Appl. No.:
10/496999
Inventors:
Ramachandran Radhakrishnan - Fremont CA, US
Gary Visor - San Diego CA, US
Peter Van Vlasselaer - Portola Valley CA, US
Richard Love - Montara CA, US
International Classification:
A61K038/21
US Classification:
424085700, 530351000
Abstract:
The present invention provides compositions and methods of treating hepatitis virus infection, particularly hepatitis C virus infection. The invention provides methods of treating a hepatitis virus infection, involving administering a first form and a second form of IFN-α to provide a multiphasic pharmacokinetic profile. The multiphasic antiviral agent serum concentration profile that is achieved effects an initial rapid drop in viral titer, followed by a further decrease in viral titer over time, to achieve a sustained viral response. The invention further provides compositions that are effective in achieving a multiphasic IFN-α profile. Compositions of the invention comprise at least a first form of interferon-α (IFN-α) that has a first pharmacokinetic profile and a second form of IFN-α that has a second pharmacokinetic profile, where the second form of IFN-α has a longer mean residence time than that of the first form of IFN-α. The invention further provides compositions comprising C-terminally modified IFN-α.

Method Of Treating Hepatitis Virus Infection With A Multiphasic Interferon Delivery Profile

View page
US Patent:
20090196853, Aug 6, 2009
Filed:
Apr 8, 2009
Appl. No.:
12/420573
Inventors:
Gary VISOR - Belmont CA, US
Peter Van Vlasselaer - Portola Valley CA, US
Assignee:
THREE RIVERS PHARMACEUTICALS, LLC - Cranberry Township PA
International Classification:
A61K 38/21
A61P 31/12
US Classification:
424 855, 424 857
Abstract:
The present invention provides methods of treating hepatitis virus infection. The methods generally involve administering a composition comprising an antiviral agent in a dosing regimen that achieves a multiphasic serum concentration profile of the antiviral agent. The dosing regimen includes dosing events that are less frequent than with currently available hepatitis therapies. The multiphasic antiviral agent serum concentration profile that is achieved using the methods of the invention effects an initial rapid drop in viral titer, followed by a further decrease in viral titer over time, to achieve a sustained viral response.

Compositions And Uses Thereof

View page
US Patent:
20100310659, Dec 9, 2010
Filed:
Mar 31, 2010
Appl. No.:
12/752035
Inventors:
Dipen Desai - Whippany NJ, US
Ralph Diodone - Breisach, DE
Zenaida Go - Clifton NJ, US
Prabha N. Ibrahim - Mountain View CA, US
Raman Iyer - Piscataway NJ, US
Hans-Juergen Mair - Loerrach, DE
Harpreet K. Sandhu - West Orange NJ, US
Navnit H. Shah - Clifton NJ, US
Gary Visor - Castro Valley CA, US
Nicole Wyttenbach - Sissach, CH
Stephan Lauper - Kaiseraugst, CH
Johannes Pudewell - Oberwil, CH
Frank Wierschem - Rheinfelden, CH
International Classification:
A61K 9/14
C07D 471/04
A61K 31/437
US Classification:
424486, 424484, 424488, 546113, 514300
Abstract:
Provided are solid dispersions, solid molecular complexes, salts and crystalline polymorphs involving propane--sulfonic acid {3-[5-(4-chloro-phenyl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluoro-phenyl}-amide.

Solid Forms Of Sulfonamides And Amino Acids

View page
US Patent:
20120122860, May 17, 2012
Filed:
May 4, 2010
Appl. No.:
13/318760
Inventors:
Gary Conard Visor - Castro Valley CA, US
Prabha N. Ibrahim - Mountain View CA, US
Wayne Spevak - Berkeley CA, US
Hanna Cho - San Francisco CA, US
Songyuan Shi - Fremont CA, US
Guoxian Wu - Foster City CA, US
International Classification:
A61K 31/538
A61K 31/437
A61K 31/506
A61P 13/12
A61K 31/496
C07D 495/04
A61P 35/00
A61P 29/00
C07D 471/04
A61K 31/5377
US Classification:
5142305, 546113, 514300, 544105, 544316, 514274, 544127, 5142345, 544331, 514275, 544122, 544362, 51425304
Abstract:
Solid forms of phenyl sulfonamide compounds of formula (I) active on protein kinases, including Raf protein kinases, are described, as well as methods of using such solid forms to treat diseases and conditions associated with activity of protein kinases, e.g. Raf protein kinases, including pain, polycystic kidney disease, melanoma and colorectal cancer.
Control profile
Gary C Visor from Redwood City, CA, age ~69 Get Report